CompletedPhase 1NCT00654160

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Studying Adenocarcinoma of the anal canal

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mayo Clinic
Principal Investigator
Robert McWilliams, MD
Mayo Clinic
Intervention
fluorouracil(drug)
Enrollment
7 enrolled
Eligibility
18-120 years · All sexes
Timeline
2008 – 2012

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00654160 on ClinicalTrials.gov

Other trials for Adenocarcinoma of the anal canal

Additional recruiting or active studies for the same condition.

See all trials for Adenocarcinoma of the anal canal →

← Back to all trials